“These guidances will help companies establish clear, well-understood compliance programs so that their relationships with these third-parties will be focused on what is best for patients. MEDEC’s approval of these guidances will help ensure the integrity of medical decision-making and promote further public confidence in our industry.”
You are here
Press Releases
Press Release | July 29, 2014
Wanda Moebius
wmoebius@advamed.org
Statement | July 25, 2014
Wanda Moebius
wmoebius@advamed.org
The Advanced Medical Technology Association (AdvaMed) today issued a statement by Stephen J. Ubl, president and CEO, commending a call by Members of Congress for the Office of the Inspector General (OIG) to study the impact of competitive bidding on patients.
Statement | July 22, 2014
Mark E. Brager
mbrager@advamed.org
“AdvaMed applauds the subcommittee for holding this important hearing on barriers to evidence development and improving communication and collaboration among patients, providers, researchers, and medical technology companies to ensure continued development of the latest treatments and cures.
Press Release | July 17, 2014
Wanda Moebius
wmoebius@advamed.org
WIIT’s newly appointed president is Nancy S. Travis, vice president, international compliance and governance at AdvaMed (the Advanced Medical Technology Association).
Statement | July 17, 2014
Mark E. Brager
mbrager@advamed.org
“The new Milken Institute report released today is an important assessment on how improved patient access to innovative medical technology can provide tremendous value to the U.S. economy, both now and in the future.
Statement | July 10, 2014
Mark E. Brager
mbrager@advamed.org
“AdvaMed commends the House for taking action on legislation to address another component of the tax code that is important to innovative and emerging growth medical technology companies.
Press Release | June 17, 2014
Mark E. Brager
mbrager@advamed.org
Medical technology prices continue their trend of consistently low growth, increasing at approximately one-third the rate of prices in the overall economy and one-fifth the rate of prices for other medical goods and services over a 23-year period, according to an updated study released today by the Advanced Medical Technology Association (AdvaMed).
Press Release | June 13, 2014
Mark E. Brager
mbrager@advamed.org
“As AdvaMed continues to expand its focus on emerging markets in the Asia-Pacific region and around the world, we applaud Ms. Weisel’s leadership in developing and implementing U.S. trade policy that helps ensure patient access to innovative, life-saving and life-enhancing treatments and cures.
Statement | June 11, 2014
Mark E. Brager
mbrager@advamed.org
“AdvaMed applauds the subcommittee for holding this important hearing on the adequacy of current economic and regulatory incentives designed to foster R&D investment in innovative medical devices, diagnostics and pharmaceuticals.
Statement | June 11, 2014
Mark E. Brager
mbrager@advamed.org
“AdvaMed commends the House for taking action on legislation to address a component of the tax code that is important to innovative and emerging growth medical technology companies."